CYP2C19 STATUS AND OUTCOMES IN THE EUCLID TRIAL
Volume: 71, Issue: 11, Pages: A2087 - A2087
Published: Mar 1, 2018
Abstract
Cytochrome P450 2C19 (CYP2C19) is a hepatic enzyme involved in metabolism of clopidogrel to its active metabolite. Polymorphisms with 2 loss-of-function (LOF) alleles lead to poor metabolism of clopidogrel, but little is known about the effects of both heterozygous state for LOF and...
Paper Details
Title
CYP2C19 STATUS AND OUTCOMES IN THE EUCLID TRIAL
Published Date
Mar 1, 2018
Volume
71
Issue
11
Pages
A2087 - A2087
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History